Wordt geladen...
The role of erenumab in the treatment of migraine
Calcitonin gene related peptide (CGRP) monoclonal antibodies (mAbs) have been the first class of specifically developed preventive treatments for migraine. Clinical trials data suggest superiority of the CGRP mAbs to placebo in terms of prevention of migraine symptoms, migraine-specific quality of l...
Bewaard in:
| Gepubliceerd in: | Ther Adv Neurol Disord |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7257830/ https://ncbi.nlm.nih.gov/pubmed/32523630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420927119 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|